Revvity Inc (RVTY)
124.82
+3.78
(+3.12%)
USD |
NYSE |
Nov 04, 16:00
124.76
-0.06
(-0.05%)
Pre-Market: 20:00
Revvity Total Liabilities (Quarterly): 5.555B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.555B |
| March 31, 2024 | 5.586B |
| December 31, 2023 | 5.692B |
| September 30, 2023 | 5.727B |
| June 30, 2023 | 6.349B |
| March 31, 2023 | 6.604B |
| December 31, 2022 | 6.747B |
| September 30, 2022 | 6.759B |
| June 30, 2022 | 7.023B |
| March 31, 2022 | 7.662B |
| December 31, 2021 | 7.859B |
| September 30, 2021 | 7.941B |
| June 30, 2021 | 4.500B |
| March 31, 2021 | 4.760B |
| December 31, 2020 | 4.225B |
| September 30, 2020 | 3.634B |
| June 30, 2020 | 3.669B |
| March 31, 2020 | 3.625B |
| December 31, 2019 | 3.725B |
| September 30, 2019 | 3.782B |
| June 30, 2019 | 3.692B |
| March 31, 2019 | 3.448B |
| December 31, 2018 | 3.391B |
| September 30, 2018 | 3.290B |
| June 30, 2018 | 3.441B |
| Date | Value |
|---|---|
| March 31, 2018 | 3.571B |
| December 31, 2017 | 3.588B |
| September 30, 2017 | 2.203B |
| June 30, 2017 | 2.166B |
| March 31, 2017 | 2.132B |
| December 31, 2016 | 2.123B |
| September 30, 2016 | 2.169B |
| June 30, 2016 | 2.106B |
| March 31, 2016 | 2.161B |
| December 31, 2015 | 2.056B |
| September 30, 2015 | 1.977B |
| June 30, 2015 | 1.962B |
| March 31, 2015 | 1.968B |
| December 31, 2014 | 2.085B |
| September 30, 2014 | 1.824B |
| June 30, 2014 | 1.881B |
| March 31, 2014 | 1.942B |
| December 31, 2013 | 1.952B |
| September 30, 2013 | 1.932B |
| June 30, 2013 | 1.951B |
| March 31, 2013 | 1.974B |
| December 31, 2012 | 1.962B |
| September 30, 2012 | 1.948B |
| June 30, 2012 | 1.916B |
| March 31, 2012 | 1.982B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.625B
Minimum
Mar 2020
7.941B
Maximum
Sep 2021
5.665B
Average
5.692B
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Bionano Genomics Inc | 49.03M |
| Avantor Inc | 7.287B |
| Bruker Corp | 4.078B |
| Azenta Inc | 332.90M |
| Harvard Bioscience Inc | 61.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.42B |
| Shareholders Equity (Quarterly) | 7.870B |
| Debt to Equity Ratio | 0.4922 |
| Current Ratio | 2.272 |
| Net Debt Paydown Yield | 0.75% |